Karyopharm files resale prospectus for up to 2.8M shares by selling stockholders; company gets no proceeds

Filed November 24, 2025 · ~1 min read

Key Changes

• high

  The prospectus covers resale of up to 2,805,688 shares of common stock by selling stockholders, including 1,317,771 shares issuable upon exercise of outstanding warrants.

  The Offering verify on EDGAR →
• high

  Karyopharm will not receive any proceeds from the sale of shares offered by this prospectus; all shares are being sold by existing stockholders.

  The Offering verify on EDGAR →
• medium

  The offering consists of 1,487,917 outstanding shares held by selling stockholders and 1,317,771 shares underlying warrants.

  The Offering verify on EDGAR →